BB vs RNAC · P/E 117, rev $549.1M vs P/E 2.1, rev $38.9M
BlackBerry Ltd (BB) versus Cartesian Therapeutics Inc. (RNAC) — a side-by-side from cached financials, not a winner call.
BlackBerry Ltd (BB) is a software - infrastructure company listed on US.
Cartesian Therapeutics Inc. (RNAC) is a biotechnology company listed on US.
Latest reported BB revenue for 2026-02-28 was $549.1M. Net income was $53.2M. Revenue was up 2.7% from 2025-02-28 to 2026-02-28. BB currently screens at market cap $6.14B and trailing P/E 116.5.
Latest reported RNAC revenue for 2024-12-31 was $38.9M. Net income was -$77.4M. Revenue was up 49.6% from 2023-12-31 to 2024-12-31. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
BB currently screens at market cap $6.14B and trailing P/E 116.5. RNAC currently screens at market cap $290.9M and trailing P/E 2.1.
Not investment advice. Open the BB and RNAC stock pages for the full models.
Not investment advice.